Indication:

Posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older:
Invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy.
Fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,Posaconazole is also indicated for the:
Prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (HSCT) recipients.

Generic Name: Posaconazole

Strength: 100mg

Dosage: Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description: Pharmacor Posaconazole modified release tablets is yellow, coated, capsule-shapred tablet containing 100 mg of posaconazole.

Segment :A

Innovator: Noxafil®

PBSListed: Yes

RPBSlisted: No

Schedule: S4

Storage Conditions: Store below 25 degrees Celsius

Active Ingredients: posaconazole 100mg

Warnings: